Stocks and Investing Stocks and Investing
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021

Tiago Fauth Maintained (ABCL) at Buy with Decreased Target to $49 on, Aug 13th, 2021


Published on 2024-10-27 17:38:54 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $51 to $49 on, Aug 13th, 2021.

Tiago, nor any peers, have made any analyst calls on ABCL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources